The Prospective Comparison of Luseogliflozin and Alpha-glucosidase on the Management of Diabetic Patients with Chronic Heart Failure and Preserved Ejection Fraction (MUSCAT-HF) trial was excluded because it focused on echocardiographic outcome and had no outcome of interest (39). This evidence concerns the gene GAA and congestive heart failure.